Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000244467 | SCV000312492 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001080135 | SCV000563162 | benign | not provided | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311389 | SCV000847162 | benign | Inborn genetic diseases | 2016-04-23 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics | RCV000244467 | SCV001476245 | benign | not specified | 2024-04-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001080135 | SCV001886123 | benign | not provided | 2019-08-02 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003457663 | SCV004180997 | benign | Developmental and epileptic encephalopathy, 18 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001080135 | SCV005288423 | benign | not provided | criteria provided, single submitter | not provided |